IO BIOTECH INC's ticker is and the CUSIP is 449778109. A total of 20 filers reported holding IO BIOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,837,119 | -29.6% | 2,055,883 | 0.0% | 0.04% | -20.0% |
| Q2 2023 | $4,029,531 | +4.8% | 2,055,883 | 0.0% | 0.06% | -3.5% |
| Q1 2023 | $3,844,501 | -18.7% | 2,055,883 | 0.0% | 0.06% | -19.7% |
| Q4 2022 | $4,728,531 | -15.1% | 2,055,883 | 0.0% | 0.07% | -31.1% |
| Q3 2022 | $5,571,000 | -42.0% | 2,055,883 | 0.0% | 0.10% | -45.8% |
| Q2 2022 | $9,601,000 | +0.2% | 2,055,883 | 0.0% | 0.19% | +8.6% |
| Q1 2022 | $9,580,000 | -6.5% | 2,055,883 | 0.0% | 0.18% | +0.6% |
| Q4 2021 | $10,243,000 | – | 2,055,883 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,277,932 | $6,408,357 | 0.50% |
| Vivo Capital, LLC | 3,015,545 | $5,895,390 | 0.41% |
| Samsara BioCapital, LLC | 1,008,437 | $1,971,494 | 0.35% |
| Avoro Capital Advisors LLC | 2,055,883 | $4,029,531 | 0.06% |
| PFM Health Sciences, LP | 612,713 | $1,197,854 | 0.05% |
| Aureus Asset Management, LLC | 43,744 | $85,520 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,200 | $259,112 | 0.01% |
| Summit Trail Advisors, LLC | 43,744 | $85,520 | 0.00% |
| Renaissance Technologies | 69,100 | $135 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,854,185 | $3,624,932 | 0.00% |